CDKN2A and cancer: Indirect mechanisms of phosphorylation dependent regulation of TopI has previously been reported by the Gjerset group showing that hyperphosphorylated TopI forms a complex with the p14ARF tumor suppressor and that p14ARF may play a role in modulating TopI activity and CPT sensitivity of cancer cell lines [60].